European agency panel recommends approval of J&J's Ebola vaccine

(Reuters) - A panel of the European health regulator on Friday recommended approving Johnson & Johnson's two-dose experimental vaccine for Ebola in the European Union. J&J submitted its application to the European Medicines Agency (EMA) in November for its vaccine, which targets an Ebola strain that causes the virus in most people. The company in February said it was developing a coronavirus vaccine program that would utilize the same technologies used to make the experimental Ebola vaccine...